Showing results (1481-1490 of 6,719) with videos related to
Sort By:
Pageof 672
Annals of Hematology|February 21, 2024
Recent progress in chimeric antigen receptor therapy for acute myeloid leukemiaXiangyu Wang, Yanming Zhang, Shengli XueAnnals of Hematology|February 21, 2024
Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort studyShuang Fan, Xiaodong Mo, Xiaohui Zhang, et al.Annals of Hematology|February 27, 2024
Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic NeoplasmsAlexander Streuer, Johann-Christoph Jann, Tobias Boch, et al.Annals of Hematology|February 3, 2024
Conditional survival to assess prognosis in patients with chronic lymphocytic leukemiaPascal Schlosser, Annett Schiwitza, Jonas Klaus, et al.Annals of Hematology|February 8, 2024
Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world studyLei Zhao, Jinjun Yang, Mengran Chen, et al.Annals of Hematology|February 8, 2024
The critical role of endothelial cell in the toxicity associated with chimeric antigen receptor T cell therapy and intervention strategiesQi Zhang, Xiaojian Zhu, Yi XiaoAnnals of Hematology|January 28, 2024
Leukemia and mitophagy: a novel perspective for understanding oncogenesis and resistanceYueyao Liu, Zhigui MaAnnals of Hematology|May 22, 2024
Flow-cytometry Assessment of DNA content and Immunophenotyping of Immune-cells in Lymph-node-specimens as a Potential Diagnostic Signature of Aggressiveness in B-Non-Hodgkin LymphomasDavid Azoulay, Tal Tapuchi, Ohad Ronen, et al.Annals of Hematology|May 21, 2024
Real-life use of ropeg-interferon α2b in polycythemia vera: patient selection and clinical outcomesFrancesca Palandri, F Branzanti, M Venturi, et al.Annals of Hematology|May 28, 2024
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experienceGiuseppe Mele, Daniele Derudas, Concetta Conticello, et al.Pageof 672